# A Randomized, Double-Blind, Placebo-Controlled Trial of Flumazenil for the Treatment of Obsessive Compulsive Disorder

> **NCT00997087** · PHASE2 · TERMINATED · sponsor: **Parkway Medical Center** · enrollment: 11 (actual)

## Conditions studied

- Obsessive Compulsive Disorder

## Interventions

- **DRUG:** Flumazenil

## Key facts

- **NCT ID:** NCT00997087
- **Lead sponsor:** Parkway Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-10
- **Primary completion:** 2012-12
- **Final completion:** 2012-12
- **Target enrollment:** 11 (ACTUAL)
- **Why stopped:** Study completed and data was inconclusive.
- **Last updated:** 2014-04-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00997087

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00997087, "A Randomized, Double-Blind, Placebo-Controlled Trial of Flumazenil for the Treatment of Obsessive Compulsive Disorder". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00997087. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*